Certara Valuation Multiples

Certara Overview

About Certara

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Founded

2017

HQ

Employees

1.5K

Website

certara.com

Sectors

Health Data & AnalyticsHealthTechBioTech

Financials (LTM)

Revenue: $422M

EBITDA: $134M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Certara Financials

Certara reported last 12-month revenue of $422M and EBITDA of $134M.

In the same LTM period, Certara generated $266M in gross profit, $134M in EBITDA, and $71M in net income.

Certara P&L

In the most recent fiscal year, Certara reported revenue of $419M and EBITDA of $134M.

Certara expects next 12-month revenue of XXX and NTM EBITDA of XXX

Certara Stock Performance

Certara has current market cap of $955M, and enterprise value of $1B.

Certara's stock price is $6.23.

Certara Valuation Multiples

Certara trades at 2.5x EV/Revenue multiple, and 8.0x EV/EBITDA.

Certara Financial Valuation Multiples

As of April 20, 2026, Certara has market cap of $955M and EV of $1B.

Equity research analysts estimate Certara's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Certara has a P/E ratio of 13.4x.

Certara Margins & Growth Rates

Certara's revenue in the last 12 month grew by 3%.

Certara's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Certara's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Certara's rule of X is 36% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Certara Public Comps

See public comps and valuation multiples for other Health Data & Analytics comps.

Certara M&A Activity

Certara acquired XXX companies to date.

Last acquisition by Certara was on XXXXXXXX, XXXXX. Certara acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Certara Investment Activity

Certara invested in XXX companies to date.

Certara made its latest investment on XXXXXXXX, XXXXX. Certara invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).